Impact of microbiota-mediated biotransformation of black tea polyphenols
微生物介导的红茶多酚生物转化的影响
基本信息
- 批准号:8825636
- 负责人:
- 金额:$ 47.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-01-01 至 2019-12-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcidsAddressAnimalsAnti-Inflammatory AgentsAnti-inflammatoryApoptosisBacteriaBeveragesBilateralBiologicalBiological AvailabilityBiological ProcessBiotaBlack TeaCancer EtiologyCatechinCell ProliferationCessation of lifeChemopreventive AgentColitisColonic NeoplasmsColorectal CancerComplexConsumptionDataDevelopmentDiagnosisDietDrug KineticsEconomic BurdenEnterococcus faecalisEnvironmental Risk FactorEscherichia coliExcretory functionFoodGallic acidGenerationsGerm-FreeGnotobioticGoalsHealthHealth BenefitHeart DiseasesHourHousingHumanIn VitroIndividualInflammatory Bowel DiseasesIntestinesKnowledgeLocationMalignant NeoplasmsMeasuresMediatingMetabolicMetabolic BiotransformationMetabolismMicrobeModelingMolecular WeightMono-SMusOralOrganOrganismPathologyPatientsPlasmaPlayPolymersPositioning AttributePreventiveProcessProductionRNA SequencesReportingResourcesRibosomal RNARoleSamplingSignal TransductionSpecific Pathogen FreesSystemTeaTheaflavinsTherapeuticTissuesUnited StatesUrineWild Type MouseWomanabsorptioncancer preventioncolon cancer cell linecommensal microbescostdimerenzyme activityexpectationgerm free conditiongut microbiotaimprovedinflammatory markerinsightintestinal homeostasisliquid chromatography mass spectrometrymedical complicationmenmetabolomicsmicrobialmicrobial communitymicrobiomemicroorganismnovelphenolic acidpolyphenolpreventpublic health relevancetherapeutic targettranscriptome sequencing
项目摘要
DESCRIPTION (provided by applicant): Tea is one of the most widely consumed beverages in the world, with black tea accounting for 78% of the production. Consumption of tea has been associated with many health benefits including the prevention of cancer and heart disease. These effects have been attributed to the polyphenol compounds present in tea. Numerous studies have shown that tea polyphenols including catechins, their dimers (theaflavins) and polymers (thearubigins), have anti-inflammatory and cancer preventive activities. However, theaflavins and thearubigins, the major polyphenols in black tea, have poor systematic bioavailability. Therefore, it is still unclear how these compounds could exert their biological functions. Studies have shown that higher molecular weight polyphenols are metabolized by the microbiota and their metabolites may play an important role in black tea chemopreventive action. Ring-fission products and lower molecular weight phenolic acids have been identified as the major bacterial metabolites of catechins. However, the bacterial metabolites of theaflavins and thearubigins are still unknown. Our preliminary data indicate that microbial-derived metabolites are generated from the tea polyphenol thearubigins. Our central hypothesis is that the microbiota influence the generation of black tea polyphenol-derived metabolites enhancing their bioavailability and biological activities. The goal of this project is to determine the crosstalk between bacteria and polyphenol metabolism and establish the functional consequences on development of colitis-associated colorectal cancer. Our specific aims are as follows: 1) Determine the impact of the selective microbiota on biotransformation and pharmacokinetics of black tea polyphenol-derived metabolites. 2) Determine the relationship between microbial-derived metabolites and the biological action of black tea polyphenols/metabolites in colitis-associated colorectal cancer. 3) Measure the impact of black tea polyphenols on microbial community composition and activities. This project will determine the impact of the microbiota on black tea polyphenol- mediated biological effect in Il10-/- mice. Since the microbial community is variable among individuals, our findings will provide novel insight into how the biological activity of a defined dietary product could be altered by microorganisms. This knowledge could be utilized to improve biotransformation of active food products and to enhance their biological activity in various organs including the intestine. In addition, the basic
knowledge gained from the interplay between microorganisms and dietary-derived metabolite productions could uncover novel enzymes activity and therapeutic targets.
描述(由适用提供):茶是世界上最广泛的早餐之一,红茶占生产的78%。茶的消费与许多健康益处有关,包括预防癌症和心脏病。这些作用归因于茶中存在的多酚化合物。大量研究表明,茶多酚在内,包括角肠,它们的二聚体(曲霉)和聚合物(Thearubigins)具有抗炎和癌症预防活性。然而,红茶中主要的多酚曲霉和曲木素的系统生物利用度较差。因此,尚不清楚这些化合物如何发挥其生物学功能。研究表明,较高的分子量多酚是由菌群代谢的,其代谢物可能在红茶化学预防作用中起重要作用。环形产物和较低的分子量苯酚酸已经被确定为近叶蛋白的主要细菌代谢产物。然而,黄曲霉素和硫脂素的细菌代谢产物仍然未知。我们的初步数据表明,微生物衍生的代谢产物是由茶酚曲霉蛋白产生的。我们的中心假设是,菌群会影响红茶多酚衍生的代谢产物的产生,从而增强了其生物利用度和生物学活性。该项目的目的是确定细菌与多酚代谢之间的串扰,并确定对结肠炎相关结直肠癌发展的功能后果。我们的具体目的如下:1)确定选择性微生物群对黑茶多酚衍生代谢产物的生物转化和药代动力学的影响。 2)确定微生物衍生的代谢产物与红茶多酚/代谢物在结肠炎相关的结直肠癌中的生物学作用之间的关系。 3)测量黑茶多酚对微生物群落组成和活动的影响。该项目将确定菌群对IL10 - / - 小鼠中红茶多酚介导的生物学作用的影响。由于微生物群落在个体之间是可变的,因此我们的发现将提供有关微生物如何改变定义的饮食产物生物学活性的新见解。这些知识可用于改善活性食品的生物转化,并增强其在包括肠道在内的各种器官中的生物学活性。另外,基本
从微生物与饮食衍生的代谢产物生产之间的相互作用中获得的知识可能会发现新颖的酶活性和治疗靶标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christian Jobin其他文献
Christian Jobin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christian Jobin', 18)}}的其他基金
Cancer Therapeutics and Host Response Research Program
癌症治疗和宿主反应研究计划
- 批准号:
10625756 - 财政年份:2023
- 资助金额:
$ 47.85万 - 项目类别:
Microbiota-mediated enhancement of the anti-tumor effect of natural killer cells
微生物介导的自然杀伤细胞抗肿瘤作用的增强
- 批准号:
10654555 - 财政年份:2022
- 资助金额:
$ 47.85万 - 项目类别:
Microbiota-mediated enhancement of the anti-tumor effect of natural killer cells
微生物介导的自然杀伤细胞抗肿瘤作用的增强
- 批准号:
10435626 - 财政年份:2022
- 资助金额:
$ 47.85万 - 项目类别:
Modulation of microbiome function by host-derived noncoding small RNA
宿主来源的非编码小 RNA 调节微生物组功能
- 批准号:
10415206 - 财政年份:2021
- 资助金额:
$ 47.85万 - 项目类别:
Modulation of microbiome function by host-derived noncoding small RNA
宿主来源的非编码小 RNA 调节微生物组功能
- 批准号:
10317154 - 财政年份:2021
- 资助金额:
$ 47.85万 - 项目类别:
Impact of microbiota-mediated biotransformation of black tea polyphenols
微生物介导的红茶多酚生物转化的影响
- 批准号:
9208104 - 财政年份:2015
- 资助金额:
$ 47.85万 - 项目类别:
Impact of microbiota-mediated biotransformation of black tea polyphenols
微生物介导的红茶多酚生物转化的影响
- 批准号:
9398095 - 财政年份:2015
- 资助金额:
$ 47.85万 - 项目类别:
Mechanism by which H2S-producing bacteria influence development of colorectal cancer
产H2S细菌影响结直肠癌发生的机制
- 批准号:
9024941 - 财政年份:2015
- 资助金额:
$ 47.85万 - 项目类别:
Molecular Mechanisms of Campylobacter Jejuni-induced Pathogenesis
空肠弯曲菌诱发发病的分子机制
- 批准号:
8135463 - 财政年份:2010
- 资助金额:
$ 47.85万 - 项目类别:
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
深层碳酸盐岩酸蚀裂缝中反应-非线性两相流界面演化机制研究
- 批准号:52304047
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
核苷酸代谢酶氧化修饰调控上皮干细胞命运在口腔白斑病光动力治疗复发中的机制与意义研究
- 批准号:82330029
- 批准年份:2023
- 资助金额:220 万元
- 项目类别:重点项目
RNF31通过厚壁菌代谢产物3-氧代胆碱酸调控RORγ信号轴抑制Th17细胞分化—溃疡性结肠炎干预新靶点
- 批准号:82360112
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
氨基酸转运体调控非酒精性脂肪肝的模型建立及机制研究
- 批准号:32371222
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Climate Change Effects on Pregnancy via a Traditional Food
气候变化通过传统食物对怀孕的影响
- 批准号:
10822202 - 财政年份:2024
- 资助金额:
$ 47.85万 - 项目类别:
The GROWTH Study, Glycemia Range and Offspring Weight and adiposity in response To Human milk
生长研究、血糖范围以及后代体重和肥胖对母乳的反应
- 批准号:
10595445 - 财政年份:2023
- 资助金额:
$ 47.85万 - 项目类别:
PRE-DETERMINE: Advancing Sudden Arrhythmic Death Prediction in Coronary Artery Disease in the Absence of Severe Systolic Dysfunction
预先确定:在没有严重收缩功能障碍的情况下推进冠状动脉疾病的心律失常性猝死预测
- 批准号:
10608859 - 财政年份:2023
- 资助金额:
$ 47.85万 - 项目类别:
Development of a first-in-class antiviral to address CMV drug resistance in immunocompromised patients
开发一流的抗病毒药物来解决免疫功能低下患者的 CMV 耐药性问题
- 批准号:
10766598 - 财政年份:2023
- 资助金额:
$ 47.85万 - 项目类别:
Integration of advanced imaging and multiOMICs to elucidate pro-atherogenic effects of endothelial-to-Immune cell-like transition (EndICLT)
整合先进成像和多组学技术来阐明内皮细胞向免疫细胞样转变的促动脉粥样硬化效应 (EndICLT)
- 批准号:
10606258 - 财政年份:2023
- 资助金额:
$ 47.85万 - 项目类别: